What laboratory tests are recommended for a patient presenting with lymphadenopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Lymphadenopathy Evaluation

The recommended laboratory workup for a patient presenting with lymphadenopathy should include a complete blood count with differential, peripheral blood smear, comprehensive metabolic panel, lactate dehydrogenase (LDH), and targeted infectious disease testing based on clinical presentation.

Initial Laboratory Evaluation

  • Complete blood count (CBC) with differential to evaluate for cytopenias, abnormal cell populations, lymphocytosis, or eosinophilia 1
  • Peripheral blood smear review to identify abnormal cells suggestive of hematologic malignancy 1, 2
  • Comprehensive metabolic panel including liver and renal function tests 1
  • Lactate dehydrogenase (LDH) as a marker for hemolysis or malignancy 1, 3
  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to assess for inflammatory conditions 4

Infectious Disease Workup

  • Bacterial cultures if infection is suspected, particularly for cervical lymphadenopathy 1
  • Viral studies including EBV, CMV, HIV, and hepatitis testing when clinically indicated 1, 2
  • Tuberculosis testing (PPD or interferon-gamma release assay) when granulomatous disease is suspected 1, 4
  • Specific serologies based on travel history or exposures (e.g., Brucella, fungal infections) 1

Additional Testing Based on Clinical Presentation

  • Serum protein electrophoresis and immunofixation if paraproteinemia is suspected 3, 2
  • Direct antiglobulin test (DAT) and haptoglobin if hemolysis is suspected 1
  • Thyroid function tests if thyroid dysfunction is suspected 3
  • Flow cytometry of peripheral blood for immunophenotyping if lymphoproliferative disorder is suspected 1, 2
  • β2-microglobulin as a prognostic marker for certain hematologic malignancies 3

Imaging Studies

  • CT scan of the chest, abdomen, and pelvis with contrast to document organomegaly and/or extent of lymphadenopathy 1
  • Ultrasound for initial evaluation of superficial lymphadenopathy 2, 5
  • PET/CT if transformation to aggressive lymphoma is suspected 1

Advanced Testing When Indicated

  • Bone marrow aspiration and biopsy with immunohistochemistry if abnormal cells are found in peripheral blood or if myeloproliferative/lymphoproliferative disorder is suspected 1, 2
  • Lymph node biopsy (fine-needle aspiration, core needle, or excisional) for persistent unexplained lymphadenopathy or when malignancy is suspected 4, 6
  • Molecular testing for MYD88 mutation in cases of suspected Waldenström macroglobulinemia 1

Special Considerations

  • For patients with supraclavicular, epitrochlear, or iliac lymphadenopathy, which are always abnormal, a more aggressive workup including early biopsy should be considered 6
  • Avoid administering corticosteroids before obtaining a definitive diagnosis, as they can mask histologic findings of lymphoma 4, 6
  • For lymphadenopathy persisting beyond 4 weeks or accompanied by systemic symptoms (fever, night sweats, weight loss), more extensive laboratory testing and imaging are warranted 4

Common Pitfalls to Avoid

  • Delaying bone marrow evaluation in patients with concerning peripheral blood findings 2
  • Overlooking the need for HIV testing in patients with unexplained lymphadenopathy 1
  • Failing to consider medication-induced lymphadenopathy in the differential diagnosis 6
  • Administering empiric antibiotics without appropriate cultures in cases where malignancy is a concern 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Workup for Splenomegaly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Comprehensive Coagulopathy Workup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lymphadenopathy: Evaluation and Differential Diagnosis.

American family physician, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.